Routine screening for ovarian cancer a failure: study

September 11, 2012

Routine screening for ovarian cancer is ineffective and at times can do more harm than good, a panel of cancer specialists has concluded.

"There is no existing method of screening for ovarian cancer that is effective in reducing deaths," said US Preventive Services Task Force member and chair Dr Virginia Moyer.

"In fact, a high percentage of women who undergo screening experience false-positive test results and consequently may be subjected to unnecessary harms, such as major surgery," added Moyer in a statement on the group's website and in the .

The tests include ovarian scans and blood tests that look at a marker that can be linked to the disease.

The group said they are not recommended routinely for women who do not show signs of the disease, or who have (BRCA1 and BRCA2) that put them at a greater risk of developing it.

Other medical groups already have made similar recommendations including the "" and "American Congress of Obstetricians and Gynecologists."

is fairly rare with 22,200 new cases a year in the United States and 15,500 deaths.

Explore further: U.S. panel rejects ovarian cancer screens for low-risk women

Related Stories

U.S. panel rejects ovarian cancer screening

April 10, 2012

(HealthDay) -- A leading U.S. government panel has renewed its 2004 recommendation that women at average risk for ovarian cancer not get screened for the disease.

Recommended for you

Dogs detect breast cancer from bandage: researchers

March 24, 2017

Dogs can sniff out cancer from a piece of cloth which had touched the breast of a woman with a tumour, researchers said Friday, announcing the results of an unusual, but promising, diagnostic trial.

'Jumonji' protein key to Ewing's sarcoma rampage

March 24, 2017

By the time Ewing's Sarcoma is diagnosed, primarily in teens and young adults, it has often spread from its primary site to other parts of the body, making it difficult to treat. A University of Colorado Cancer Center study ...

In a sample of blood, researchers probe for cancer clues

March 24, 2017

One day, patients may be able to monitor their body's response to cancer therapy just by having their blood drawn. A new study, led by bioengineers at UC Berkeley, has taken an important step in that direction by measuring ...

Researchers gain insight into breast cancer drug resistance

March 24, 2017

Breast cancer's ability to develop resistance to treatment has frustrated researchers and physicians and has thwarted even the latest and greatest targeted therapies. For example, after researchers identified a disease pathway ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.